Home  /  Resource Library  /  Complex Karyotype Is a Significant Predictor for Worst Outcomes in Patients with Mantle Cell Lymphoma (MCL) Treated with BTK Inhibitors – Comprehensive Analysis of 396 Patients

Complex Karyotype Is a Significant Predictor for Worst Outcomes in Patients with Mantle Cell Lymphoma (MCL) Treated with BTK Inhibitors – Comprehensive Analysis of 396 Patients

ASH 2020: Study examined complex karyotype abnormalities as a predictor of outcome in patients with mantle cell lymphoma treated with btk inhibitors.